Affinage

Showing ARHGAP8BPGAP1 is a alias.

ARHGAP8

Rho GTPase-activating protein 8 · UniProt P85298

Length
464 aa
Mass
53.5 kDa
Annotated
2026-06-09
15 papers in source corpus 10 papers cited in narrative 10 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 7/7 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

ARHGAP8 (BPGAP1) is a multidomain RhoGAP scaffold that couples the inactivation of RhoA to the spatial coordination of cytoskeletal remodeling, receptor trafficking, and ERK signaling (PMID:12944407, PMID:36598812). Through its C-terminal GAP domain it selectively enhances RhoA inactivation, an activity required, together with its N-terminal BCH/Sec14p-like domain, for pseudopodia formation, while its central proline-rich motif (182-PPPRPPLP-189) drives enhanced cell migration (PMID:12944407, PMID:15225876). This proline-rich motif is a direct SH3-binding module: it engages the SH3 domain of cortactin to recruit cortactin to the cell periphery and promote motility, and binds EEN/endophilin II to drive EGF receptor endocytosis and ERK1/2 activation in a manner dependent on intact GAP catalytic activity (PMID:15064355, PMID:15944398). ARHGAP8 operates as a dual-function scaffold that simultaneously down-regulates local RhoA via its GAP domain and recruits the RacGEF Vav1 upon EGF stimulation to activate Rac1, promoting lamellipodia, polarized motility, invadopodium formation, and extravasation (PMID:36598812). Its scaffolding outputs are gated by post-translational and partner-mediated control: Pin1 binds the GAP domain to relieve autoinhibition and enhance RhoA-directed GAP activity, with active Mek2 bridging this interaction, while JNK phosphorylation at Ser424 unlocks an autoinhibitory conformation that allows ARHGAP8 to scaffold the MP1/MEK1 complex on late endosomes and drive proliferation through an ERK-Myc-CyclinA axis (PMID:20179103, PMID:28092672). The BCH domain additionally targets K-Ras to induce ERK activation and PC12 neuritogenesis, an output restrained by SmgGDS (PMID:23155002). In neurons, ARHGAP8 localizes to excitatory synapses with GluN2B-containing NMDA receptors and regulates dendritic spine morphology and AMPA receptor-mediated transmission (PMID:41862576).

Mechanistic history

Synthesis pass · year-by-year structured walk · 10 steps
  1. 2003 High

    Establishing whether ARHGAP8 is a genuine RhoA regulator and which domains drive cell-shape changes defined it as a RhoA-selective GAP with separable domain functions.

    Evidence In vivo GAP activity assay, pull-down/Co-IP, and domain-deletion microscopy with dominant-negative/constitutively-active GTPases

    PMID:12944407

    Open questions at the time
    • Did not resolve the structural basis of BCH-domain homo/heterophilic complex formation
    • Direct GTPase substrate selectivity beyond RhoA not exhaustively mapped
  2. 2004 High

    Identifying the proline-rich motif's SH3 partner explained how ARHGAP8 enhances migration, linking it physically to the actin regulator cortactin.

    Evidence MALDI-MS, Co-IP, point-mutant analysis (P184A/P186A), co-localization and migration assays

    PMID:15064355

    Open questions at the time
    • Did not establish whether cortactin recruitment depends on GAP activity
    • Quantitative actin dynamics downstream of cortactin translocation not measured
  3. 2004 Medium

    Genomic and domain characterization placed ARHGAP8 in a defined multidomain architecture with alternatively spliced BCH-region variants.

    Evidence Genomic cloning, sequence/domain analysis, RT-PCR and PCR-SSCP

    PMID:15225876

    Open questions at the time
    • No functional assays of the domains in this study
    • Functional differences between splice variants not tested
  4. 2005 High

    Showing the same proline-rich motif binds EEN/endophilin II connected ARHGAP8 to receptor trafficking and demonstrated GAP activity is required for EGFR endocytosis-coupled ERK signaling.

    Evidence MALDI-MS, pull-down/Co-IP, interaction-motif and catalytic-domain mutagenesis, endocytosis and ERK1/2 assays

    PMID:15944398

    Open questions at the time
    • Mechanistic link between RhoA inactivation and endocytic machinery not fully resolved
    • Competition between cortactin and EEN for the same motif not addressed
  5. 2010 High

    Defining Pin1 as a GAP-domain partner revealed a prolyl-isomerization switch, scaffolded by active Mek2, that relieves autoinhibition and tunes GAP activity and ERK output.

    Evidence Reciprocal Co-IP, domain/point mutagenesis, kinase-dead Mek2 controls, Pin1 knockdown/rescue, ERK and migration assays

    PMID:20179103

    Open questions at the time
    • Structural model of the autoinhibited vs released conformation not determined
    • In vivo relevance of Pin1 regulation not tested
  6. 2012 High

    Identifying the BCH domain as a K-Ras-targeting module extended ARHGAP8 function to Ras-ERK-driven differentiation, restrained by SmgGDS.

    Evidence Domain-mutant expression, dominant-negative K-Ras/Mek2, SmgGDS knockdown, ERK and PC12 differentiation assays

    PMID:23155002

    Open questions at the time
    • Direct BCH-domain/K-Ras binding affinity not quantified
    • Mechanism of SmgGDS antagonism unresolved
  7. 2017 High

    Mapping JNK phosphorylation at Ser424 explained how ARHGAP8 is licensed to scaffold MP1/MEK1 on late endosomes, coupling endosomal ERK signaling to proliferation and transformation.

    Evidence Phospho-site mutagenesis, endosomal fractionation, Rab GTPase screen, ERK and proliferation/transformation assays

    PMID:28092672

    Open questions at the time
    • Upstream trigger for JNK activation in this context not defined
    • Whether endosomal and plasma-membrane functions are mutually exclusive not addressed
  8. 2023 High

    Demonstrating Vav1 recruitment and Rac1 activation alongside RhoA inactivation established ARHGAP8 as a dual-function scaffold that spatially partitions Rho-GTPase signaling during motility.

    Evidence Co-IP (Rac1, Vav1), live-cell imaging, RhoA/Rac1 activity assays, invadopodium and extravasation assays, domain deletions

    PMID:36598812

    Open questions at the time
    • Precise structural basis for inactive-Rac1 binding not resolved
    • How RhoA inactivation mechanistically gates Rac1 binding remains incompletely defined
  9. 2026 Medium

    Localizing ARHGAP8 to excitatory synapses with GluN2B linked it to dendritic spine morphology and AMPA receptor transmission, extending its role to neuronal function.

    Evidence Neuronal overexpression, synaptic localization/co-localization imaging, spine morphology, AMPA receptor electrophysiology

    PMID:41862576

    Open questions at the time
    • Single-lab finding lacking independent replication
    • Endogenous loss-of-function synaptic phenotype not established
    • Direct ARHGAP8-GluN2B physical interaction not demonstrated
  10. 2025 Medium

    A noncanonical RhoB/C-ROCK2 axis was implicated in ARHGAP8-driven synaptic pathology under lncRNA/miRNA control.

    Evidence In vivo hippocampal overexpression, RhoA/ROCK2 activity assays, miRNA sponge/knockdown, spine imaging, synaptic EM

    PMID:41168987

    Open questions at the time
    • Single-lab study; noncanonical ROCK2 activation requires independent replication
    • Direct molecular link between ARHGAP8 and RhoB/C activation not defined
    • Causal role of the THUMPD3-AS1/miR-485-5p axis on endogenous ARHGAP8 not fully established

Open questions

Synthesis pass · forward-looking unresolved questions
  • How ARHGAP8's distinct outputs—cytoskeletal motility, endosomal ERK scaffolding, and synaptic regulation—are coordinated in time and space within a single cell remains unresolved.
  • No integrated structural model of autoinhibition and partner switching
  • Endogenous, physiological loss-of-function phenotypes across tissues not defined
  • Whether scaffolding partners compete for the shared proline-rich motif in vivo is unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 4 GO:0098772 molecular function regulator activity 3 GO:0140096 catalytic activity, acting on a protein 2 GO:0008092 cytoskeletal protein binding 1
Localization
GO:0005856 cytoskeleton 2 GO:0005886 plasma membrane 2 GO:0005768 endosome 1
Pathway
R-HSA-162582 Signal Transduction 4 R-HSA-5653656 Vesicle-mediated transport 2 R-HSA-112316 Neuronal System 1
Complex memberships
MP1/MEK1 scaffold complex

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2003 BPGAP1/ARHGAP8 selectively enhanced RhoA GTPase activity in vivo, and formed homophilic or heterophilic complexes with other BCH domain-containing proteins via pull-down and co-immunoprecipitation. Pseudopodia formation required both the BCH and GAP domains but not the proline-rich region, while enhanced cell migration required the proline-rich region. Constitutively active RhoA, or dominant-negative Cdc42 and Rac1, differentially inhibited pseudopodia formation. In vivo GAP activity assay, pull-down, co-immunoprecipitation, deletion mutant fluorescence microscopy, dominant-negative/constitutively-active GTPase co-expression The Journal of biological chemistry High 12944407
2004 BPGAP1/ARHGAP8 directly interacts with cortactin via its proline-rich motif 182-PPPRPPLP-189 binding to the SH3 domain of cortactin, both in vitro and in vivo. Together they co-localize to the cell periphery and enhance cell migration. Alanine substitution of prolines at positions 184 and 186 abolished the interaction, prevented cortactin translocation to the periphery, and eliminated enhanced cell migration. Protein precipitation, MALDI mass spectrometry, co-immunoprecipitation, deletion/point-mutant analysis, fluorescence co-localization, cell migration assay Molecular biology of the cell High 15064355
2004 BPGAP1/ARHGAP8 contains a C-terminal RhoGAP domain, a central SH3-binding proline-rich motif, and an N-terminal BCH/Sec14p-like domain, sharing identical genomic organization with ARHGAP1/CDC42GAP/p50RHOGAP. Three alternatively spliced transcripts differ only in the BCH/Sec14p-like domain region. Genomic cloning, sequence analysis, domain characterization, RT-PCR, PCR-SSCP Gene Medium 15225876
2005 BPGAP1/ARHGAP8 interacts directly with EEN/endophilin II via the SH3 domain of EEN binding to the proline-rich region 182-PPPRPPLP-189 of BPGAP1, with prolines 184 and 186 being indispensable. Overexpression of EEN together with wild-type BPGAP1 enhanced EGF-stimulated receptor endocytosis and ERK1/2 phosphorylation; a catalytically inactive GAP domain mutant of BPGAP1 blocked both EGF receptor endocytosis and ERK1/2 augmentation, indicating the GAP activity is required. Protein precipitation, MALDI mass spectrometry, pull-down, co-immunoprecipitation, deletion/point-mutant analysis, receptor endocytosis assay, ERK1/2 phosphorylation assay Journal of cell science High 15944398
2010 The RhoGAP domain of BPGAP1/ARHGAP8 interacts with the peptidyl-prolyl isomerase Pin1, leading to enhanced GAP activity toward RhoA. Active Mek2 (but not kinase-dead Mek2) acts as a scaffold to bridge Pin1 and BPGAP1, releasing autoinhibition of the proline-rich motif 186-PPLP-189 and making non-canonical motifs 186-PPLP-189 and 256-DDYGD-260 accessible for concerted binding by the WW and PPI domains of Pin1. Pin1 knockdown caused super-induction of BPGAP1-induced acute ERK activation after EGF stimulation; re-introducing wild-type but not catalytic or non-binding Pin1 mutants reversed this and inhibited cell migration induced by BPGAP1 and active Mek2. Co-immunoprecipitation, domain deletion/point-mutant analysis, Pin1 knockdown/rescue, kinase-dead Mek2 mutant, ERK activation assay, cell migration assay Journal of cell science High 20179103
2012 The BCH domain of BPGAP1/ARHGAP8 specifically targets K-Ras to induce robust ERK activation and PC12 cell differentiation/neuritogenesis. This effect was inhibited by dominant-negative Mek2 (K101A) and dominant-negative K-Ras (S17N), and also by SmgGDS. SmgGDS knockdown super-induced K-Ras activation and PC12 differentiation mediated by the BCH domain. Domain deletion/mutant expression, dominant-negative GTPase and kinase constructs, SmgGDS siRNA knockdown, ERK activation assay, PC12 differentiation assay Molecular biology of the cell High 23155002
2017 BPGAP1/ARHGAP8 promotes MP1-induced ERK activation on late endosomes by scaffolding the MP1/MEK1 complex. This scaffolding function requires phosphorylation of BPGAP1 by JNK at Ser424 in the C-terminal tail, which unlocks its autoinhibitory conformation. Phosphorylated BPGAP1 facilitates endosomal ERK signaling transduction to the nucleus, driving cell proliferation and transformation via the ERK-Myc-CyclinA axis. Protein interaction studies, phosphorylation site mutagenesis (Ser424), endosomal fractionation, ERK signaling assays, cell proliferation/transformation assays, Rab GTPase screen Oncogene High 28092672
2023 ARHGAP8/BPGAP1 binds inactive Rac1 and localizes to lamellipodia. Under EGF stimulation, BPGAP1 recruits the RacGEF Vav1 to activate Rac1, promoting polarized cell motility, spreading, invadopodium formation, and cell extravasation. BPGAP1 simultaneously down-regulates local RhoA activity via its RhoGAP domain, and this RhoA inactivation influences Rac1 binding to BPGAP1 and its subsequent activation by Vav1. Thus BPGAP1 acts as a dual-function scaffold coordinating Rac1 activation and RhoA inactivation. Co-immunoprecipitation (Rac1, Vav1, BPGAP1), live-cell fluorescence imaging, lamellipodia localization, RhoA/Rac1 activity assays, invadopodium formation assay, cell extravasation assay, domain deletion analysis Molecular biology of the cell High 36598812
2026 ARHGAP8 localizes to excitatory synapses in hippocampal neurons, with synaptic localization linked to the NMDA receptor subunit GluN2B. Increasing ARHGAP8 levels reduced dendritic complexity and spine volume, and caused a significant decrease in synaptic AMPA receptor-mediated transmission. Neuronal overexpression, synaptic localization imaging, co-localization with GluN2B, spine morphology analysis, electrophysiology (AMPA receptor-mediated transmission) Communications biology Medium 41862576
2025 ARHGAP8 suppresses RhoA activity but activates ROCK2 through RhoB/C-mediated compensatory mechanisms (noncanonical pathway). Hyperactivation of ROCK2 via this pathway disrupts actin cytoskeletal remodeling, increases immature dendritic spines, and causes synaptic ultrastructural defects. In vivo, this regulatory axis links the lncRNA THUMPD3-AS1 and miR-485-5p to ARHGAP8-driven synaptic pathology. In vivo overexpression (ventral hippocampus), RhoA/ROCK2 activity assays, miRNA sponge/knockdown experiments, dendritic spine imaging, synaptic ultrastructure electron microscopy Advanced science Medium 41168987

Source papers

Stage 0 corpus · 15 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2004 ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers. Gene 46 15225876
2003 Concerted regulation of cell dynamics by BNIP-2 and Cdc42GAP homology/Sec14p-like, proline-rich, and GTPase-activating protein domains of a novel Rho GTPase-activating protein, BPGAP1. The Journal of biological chemistry 44 12944407
2004 BPGAP1 interacts with cortactin and facilitates its translocation to cell periphery for enhanced cell migration. Molecular biology of the cell 43 15064355
2005 Activation of EGF receptor endocytosis and ERK1/2 signaling by BPGAP1 requires direct interaction with EEN/endophilin II and a functional RhoGAP domain. Journal of cell science 42 15944398
2018 Bipolar disorder with binge eating behavior: a genome-wide association study implicates PRR5-ARHGAP8. Translational psychiatry 22 29391396
2010 Active Mek2 as a regulatory scaffold that promotes Pin1 binding to BPGAP1 to suppress BPGAP1-induced acute Erk activation and cell migration. Journal of cell science 22 20179103
2017 BPGAP1 spatially integrates JNK/ERK signaling crosstalk in oncogenesis. Oncogene 16 28092672
2023 The scaffold RhoGAP protein ARHGAP8/BPGAP1 synchronizes Rac and Rho signaling to facilitate cell migration. Molecular biology of the cell 13 36598812
2012 SmgGDS antagonizes BPGAP1-induced Ras/ERK activation and neuritogenesis in PC12 cell differentiation. Molecular biology of the cell 11 23155002
2003 Identification and characterization of a gene encoding a putative mouse Rho GTPase activating protein gene 8, Arhgap8. Gene 8 12559566
2004 Filling the GAPs in cell dynamics control: BPGAP1 promotes cortactin translocation to the cell periphery for enhanced cell migration. Biochemical Society transactions 6 15506981
2025 LncRNA THUMPD3-AS1 Regulates Behavioral and Synaptic Structural Abnormalities in Schizophrenia via miR-485-5p and ARHGAP8. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2 41168987
2026 Bioinformatics and machine learning integration reveals a novel 4-gene (GFUS, ARHGAP8, NBL1, and ACTB) biomarker model for prostate cancer. Discover oncology 1 41721923
2026 Neuronal ARHGAP8 controls synapse structure and AMPA receptor-mediated synaptic transmission. Communications biology 1 41862576
2024 [Application of ARHGAP8 in Predicting the Efficacy of Neoadjuvant Chemotherapy for Locally Advanced Mid-Low Rectal Cancer]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 1 39223018

Missed literature

Know a paper Affinage missed for ARHGAP8? Flag it for the maintainers and the community.

No submissions yet.